Clinical trials - Press Releases

Date	Title	Company
12-Jan-2021	Lilly’s Donanemab Slows Clinical Decline of Alzheimer’s Disease in Positive Phase 2 Trial	Donanemab
12-Jan-2021	ICON Supports Pfizer and BioNTech on the Investigational COVID-19 Vaccine Trial	ICON plc
12-Jan-2021	Byondis Announces Upcoming Presentation at J.P. Morgan Healthcare Conference	Byondis
12-Jan-2021	Bone Therapeutics treats first patients in ALLOB Phase IIb tibial fracture study	Bone Therapeutics
12-Jan-2021	OncoHost Welcomes Nobel Prize Winner to Scientific Advisory Board	OncoHost
11-Jan-2021	Darren Green, GSK, conference chair invites you to attend AI in Drug Discovery Virtual Conference	SMi Group
10-Jan-2021	Gene Therapy Market 2021 Size, Share, Booming Segments Breakdown and Detailed SWOT Analysis \| Global Players are AveXis, Novartis, REGENXBIO	MarketDigits
10-Jan-2021	Psychedelic Drugs Market 2021 to Witness Robust Expansion by 2026 \| Global Players are COMPASS, ALLERGAN, The Emmes Company, F. Hoffmann-La Roche, Pfizer, Mylan N.V.	MarketDigits
07-Jan-2021	Phesi and Sensyne Health Agree Collaboration to Advance Development of Synthetic Arms in Clinical Trials	Phesi
07-Jan-2021	Global Clinical Trials Market Is Estimated To Grow Positive Long-Term Growth Outlook \| Eli Lilly and Company, Novo Nordisk A/S, Ranbaxy Laboratories Ltd.	Marketresearch.biz
06-Jan-2021	Exostar Receives Kantara Initiative’s Identity Assurance Trust Framework Certification, Achieves Healthcare and Life Science Community Milestones	Exostar
06-Jan-2021	Cellnutrition Health Introduces Promising New Vaccine and Immunotherapy	Cellnutrition
05-Jan-2021	Phase 2b clinical trial of XF-73 completes patient recruitment	Destiny Pharma plc
04-Jan-2021	Panthera began dosing volunteers in AstraZeneca’s phase III of its long-acting antibody combination AZD7442 for the prevention of COVID-19 at its sites in Preston, North Manchester and North London	Panthera Biopartners
04-Jan-2021	Stefan Przyborski from University of Durham invites you to join 3D Cell Culture Virtual Conference	SMi Group
24-Dec-2020	Innovative drug, Carrimycin, Receives FDA Approval for International, Multi-country Phase III Clinical Trial for the treatment of severe COVID-19 in hospitalized patients	Shenyang Tonglian Group Co., Ltd
23-Dec-2020	Amryt Granted Orphan Drug Designation by the FDA for AP103	Amryt
23-Dec-2020	CURRANZ AWARDED TWO ACCOLADES AT THE EUROPEAN SPECIALIST SPORTS NUTRITION ALLIANCE AWARDS 2020	CurraNZ
23-Dec-2020	UPM Biochemicals grows lignin business with new Domtar supply agreement	UPM Biochemicals
22-Dec-2020	VFMCRP and ChemoCentryx provide topline results from ACCOLADE trial of avacopan in C3 glomerulopathy including improved estimated glomerular filtration rate (eGFR)	Vifor Fresenius Medical Care Renal Pharma (VFMCRP)